ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
2,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
4,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
6,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
7,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
8,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
9,1,Visual field defect,Visual field disorders,Vision disorders,Eye,N
10,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
10,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
11,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
12,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
13,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
14,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
15,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
16,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
16,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
17,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
17,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
18,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
18,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
19,1,Prostatic disorder,"Prostatic signs, symptoms and disorders NEC",Prostatic disorders (excl infections and inflammations),Repro,N
20,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
21,1,Pericardial haemorrhage,Pericardial disorders NEC,Pericardial disorders,Card,Y
22,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
23,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
24,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
24,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
25,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
26,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
26,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
27,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
28,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
28,2,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
29,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
30,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
30,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
30,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
30,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
30,5,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
30,6,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
31,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
31,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
31,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
31,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
32,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
32,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
33,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
33,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
34,1,Chemical burns of eye,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
34,2,Corneal opacity,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
34,3,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
34,4,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
35,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
35,2,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
36,1,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
36,2,Headache,Headaches NEC,Headaches,Nerv,N
36,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
37,1,Application site bruise,Application site reactions,Administration site reactions,Genrl,N
38,1,Burns third degree,Thermal burns,Injuries by physical agents,Inj&P,N
39,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
39,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
39,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
40,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
41,1,Deafness,Hearing losses,Hearing disorders,Ear,N
42,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
43,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
44,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
45,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
46,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
47,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
48,1,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
49,1,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
49,2,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
50,1,5'nucleotidase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
50,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
50,3,Anisochromia,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
50,4,Anisocytosis,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
50,5,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
50,6,Bromosulphthalein test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
50,7,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
50,8,Epigastric discomfort,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
50,9,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
50,10,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
50,11,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
50,12,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
50,13,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
50,14,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
50,15,Iron deficiency,Iron deficiencies,Iron and trace metal metabolism disorders,Metab,N
50,16,Iron deficiency anaemia,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
50,17,Liver palpable,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
50,18,Liver scan abnormal,Hepatobiliary imaging procedures,Hepatobiliary investigations,Inv,N
50,19,Neutrophil toxic granulation present,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
50,20,Occult blood positive,Faecal analyses NEC,Gastrointestinal investigations,Inv,N
50,21,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
50,22,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
51,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
51,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
51,3,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
51,4,Disinhibition,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
51,5,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
51,6,Headache,Headaches NEC,Headaches,Nerv,N
51,7,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
51,8,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
51,9,Marital problem,Family and partner issues,Family issues,SocCi,N
51,10,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
51,11,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
51,12,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
51,13,Paranoid personality disorder,Personality disorders with eccentric behaviour (Cluster A),Personality disorders and disturbances in behaviour,Psych,N
51,14,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
51,15,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
51,16,Suspiciousness,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
52,1,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
53,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
53,2,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
54,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
54,2,Bronchial disorder,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
54,3,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
54,4,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
54,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
54,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
54,7,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
54,8,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
54,9,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
54,10,Nocturnal dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
54,11,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
54,12,Rales,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
54,13,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
54,14,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
54,15,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
54,16,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
54,17,Respiration abnormal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
54,18,Respiratory tract inflammation,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
54,19,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
55,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
55,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
55,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
55,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
56,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
56,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
56,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
56,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
56,5,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
57,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
57,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
58,1,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
59,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
59,2,Exposure via direct contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
59,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
59,4,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
59,5,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
59,6,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
60,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
60,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
61,1,Lip discolouration,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
62,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
62,2,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
62,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
62,4,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
63,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
63,2,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
64,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
65,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
65,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
66,1,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
67,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
67,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
67,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
67,4,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
67,5,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
67,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
67,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
67,8,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
67,9,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
67,10,Temperature intolerance,Feelings and sensations NEC,General system disorders NEC,Genrl,N
68,1,Lip pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
68,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
69,1,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
69,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
69,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
69,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
70,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
70,2,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
70,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
71,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
71,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
71,3,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
72,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
72,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
72,3,Muscle disorder,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
72,4,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
72,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
72,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
73,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
73,2,Exposure via ingestion,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
73,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
74,1,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
74,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
75,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
76,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
76,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
76,3,Product counterfeit,"Counterfeit, falsified and substandard products","Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
76,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
76,5,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
77,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
77,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
78,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
78,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
78,3,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
79,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
79,2,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
79,3,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
80,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
80,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
80,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
81,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
82,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
82,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
82,3,Suspected counterfeit product,"Counterfeit, falsified and substandard products","Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
83,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
83,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
84,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
84,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
84,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
84,4,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
85,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
85,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
85,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
85,4,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
86,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
86,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
87,1,Chapped lips,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
87,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
87,3,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
87,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
87,5,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
88,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
88,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
88,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
88,4,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
88,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
88,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
88,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
88,8,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
88,9,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
89,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
89,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
89,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
89,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
89,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
90,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
90,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
90,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
91,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
91,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
92,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
92,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
92,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
93,1,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
94,1,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
94,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
94,3,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
95,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
95,2,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
96,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
97,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
97,2,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
98,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
98,2,Application site dryness,Application site reactions,Administration site reactions,Genrl,N
98,3,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
98,4,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
98,5,Application site pain,Application site reactions,Administration site reactions,Genrl,N
98,6,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
98,7,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
98,8,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
99,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
99,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
100,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
100,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
101,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
101,2,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
101,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
101,4,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
101,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
101,6,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
101,7,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
101,8,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
101,9,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
101,10,Skin wound,Skin injuries NEC,Injuries NEC,Inj&P,N
101,11,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
102,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
102,2,Headache,Headaches NEC,Headaches,Nerv,N
102,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
102,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
102,5,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
102,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
103,1,Exposure via inhalation,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
103,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
103,3,Headache,Headaches NEC,Headaches,Nerv,N
103,4,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
103,5,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
104,1,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
104,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
104,3,Headache,Headaches NEC,Headaches,Nerv,N
104,4,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
104,5,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
104,6,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
105,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
105,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
106,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
106,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
107,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
107,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
107,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
107,4,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
108,1,Product contamination physical,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
108,2,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
109,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
109,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
109,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
110,1,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
110,2,Suspected counterfeit product,"Counterfeit, falsified and substandard products","Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
111,1,Application site discolouration,Application site reactions,Administration site reactions,Genrl,N
112,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
113,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
114,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
115,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
115,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
115,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
116,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
117,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
117,2,Macule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
117,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
117,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
117,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
117,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
118,1,Application site erosion,Application site reactions,Administration site reactions,Genrl,N
118,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
118,3,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
118,4,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
118,5,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
118,6,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
119,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
119,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
119,3,Nasal disorder,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
120,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
121,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
121,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
121,3,Skin discomfort,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
121,4,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
121,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
122,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
122,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
123,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
123,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
123,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
124,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
124,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
125,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
126,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
126,2,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
127,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
127,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
128,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
128,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
129,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
130,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
130,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
131,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
131,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
132,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
132,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
133,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
133,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
133,3,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
134,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
135,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
135,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
136,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
136,2,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
137,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
137,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
137,3,Exposure via inhalation,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
137,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
137,5,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
137,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
137,7,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
138,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
138,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
138,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
138,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
138,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
138,6,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
139,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
139,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
139,3,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
139,4,Application site pain,Application site reactions,Administration site reactions,Genrl,N
140,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
140,2,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
140,3,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
140,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
140,5,Suspected counterfeit product,"Counterfeit, falsified and substandard products","Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
141,1,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
141,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
141,3,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
141,4,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
141,5,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
141,6,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
141,7,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
141,8,Suspected product tampering,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
141,9,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
142,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
143,1,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
144,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
144,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
145,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
145,2,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
145,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
145,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
145,5,Lip ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
145,6,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
145,7,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
145,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
145,9,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
145,10,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
146,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
146,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
146,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
146,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
147,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
147,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
147,3,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
147,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
147,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
147,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
148,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
148,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
148,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
148,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
148,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
149,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
149,2,Exposure via ingestion,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
149,3,Exposure via skin contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
149,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
149,5,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
149,6,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
150,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
151,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
152,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
152,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
152,3,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
152,4,Paranasal sinus discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
152,5,Product leakage,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
152,6,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
153,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
153,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
154,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
155,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
155,2,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
155,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
156,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
156,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
156,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
157,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
157,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
158,1,Lip pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
159,1,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
160,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
161,1,Product contamination physical,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
161,2,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
162,1,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
163,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
163,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
163,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
164,1,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
165,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
166,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
166,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
167,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
167,2,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
167,3,Exposure via eye contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
167,4,Exposure via skin contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
167,5,Eye abrasion,Eye injuries NEC,Injuries NEC,Inj&P,N
167,6,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
167,7,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
167,8,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
167,9,Thermal burns of eye,Thermal burns,Injuries by physical agents,Inj&P,N
167,10,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
168,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
169,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
170,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
170,2,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
170,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
170,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
171,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
171,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
171,3,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
172,1,Headache,Headaches NEC,Headaches,Nerv,N
173,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
173,2,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
174,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
175,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
176,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
176,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
176,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
176,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
176,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
177,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
178,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
178,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
178,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
178,4,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
178,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
179,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
179,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
179,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
180,1,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
180,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
180,3,Headache,Headaches NEC,Headaches,Nerv,N
180,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
181,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
181,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
182,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
182,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
182,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
182,4,Therapeutic product ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
183,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
183,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
184,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
184,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
184,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
184,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
184,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
185,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
185,2,Lip haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
185,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
185,4,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
186,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
187,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
187,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
187,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
187,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
188,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
189,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
189,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
190,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
191,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
192,1,Device material issue,Device physical property and chemical issues,Device issues,Prod,N
192,2,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
193,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
194,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
195,1,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
196,1,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
196,2,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
196,3,Suspected counterfeit product,"Counterfeit, falsified and substandard products","Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
197,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
197,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
197,3,Eyelid margin crusting,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
197,4,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
197,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
198,1,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
198,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
198,3,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
199,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
199,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
199,3,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
199,4,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
199,5,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
199,6,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
200,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
201,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
201,2,Application site erosion,Application site reactions,Administration site reactions,Genrl,N
201,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
201,4,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
201,5,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
201,6,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
201,7,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
201,8,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
